Related Experiment Videos
[In vivo effects of cefoperazone in local infection]
Abstract:
The in vivo antibacterial activity and the penetration into inflammatory tissues of cefoperazone (CPZ) were compared with those of cefotiam (CTM) in local infection systems using mouse subcutaneous abscess and rat granuloma pouch. The serum levels of CPZ in subcutaneous abscess in mice caused by Staphylococcus aureus F-230 (penicillinase producing strain) were lower than that of CTM, but there was no significance between the therapeutic effects of both drugs. The same results were obtained using Staphylococcus aureus F-196 (penicillinase non-producing strain). When infected with Enterobacter cloacae H-27 (cephalosporinase producing strain) in rat granuloma pouch, the exudate levels of CTM were lower than those of CPZ. Judging from these results, it was suggested that CPZ was a useful antibiotic for the treatment of bacterial-inflammatory tissues.
Insights
Cefoperazone (CPZ) and cefotiam (CTM) showed comparable therapeutic effects in treating bacterial infections, with CPZ demonstrating better penetration into inflammatory tissues. This suggests CPZ is effective for treating bacterial-inflammatory conditions.
Area of Science:
- Pharmacology
- Infectious Diseases
- Microbiology
Background:
- Antibiotic resistance is a growing concern, necessitating the development of effective treatments for bacterial infections.
- Understanding drug penetration into infected tissues is crucial for optimizing therapeutic outcomes.
Purpose of the Study:
- To compare the in vivo antibacterial activity and tissue penetration of cefoperazone (CPZ) and cefotiam (CTM).
- To evaluate the efficacy of CPZ and CTM in treating local infections in established animal models.
Main Methods:
- Utilized mouse subcutaneous abscess and rat granuloma pouch models to simulate local bacterial infections.
- Administered CPZ and CTM and measured their serum and exudate levels.
- Assessed the therapeutic effects of both antibiotics against Staphylococcus aureus and Enterobacter cloacae.
Main Results:
- Serum levels of CPZ were lower than CTM in mouse models with Staphylococcus aureus infections, but therapeutic effects were similar.
- In rat granuloma pouch models with Enterobacter cloacae, exudate levels of CTM were lower than CPZ.
- Both antibiotics demonstrated therapeutic effects, with variations in tissue penetration observed.
Conclusions:
- Cefoperazone (CPZ) exhibits useful antibiotic activity for treating bacterial-inflammatory tissues.
- CPZ's penetration into inflammatory tissues suggests its potential as a valuable therapeutic agent.
- Further research may explore CPZ's specific advantages in targeting localized bacterial infections.